Cormorant Asset Management, LLC Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Cormorant Asset Management, LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Cormorant Asset Management, LLC. Cormorant Asset Management, LLC is 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Apellis Pharmaceuticals, Inc. ($APLS) and in Atea Pharmaceuticals, Inc. ($AVIR) and in Avidity Biosciences, Inc. ($RNA) and 10% Owner in Axonics Modulation Technologies, Inc. ($AXNX) and 10% Owner in Turning Point Therapeutics, Inc. ($TPTX) and 10% Owner in Kezar Life Sciences, Inc. ($KZR) and in Prometheus Biosciences, Inc. ($RXDX) and in Rain Therapeutics Inc. ($RAIN) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in Olema Pharmaceuticals, Inc. ($OLMA) and in BioAtla, Inc. ($BCAB) and Director in Biomea Fusion, Inc. ($BMEA).

Latest Insider Trading Transactions of Cormorant Asset Management, LLC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, APLS, AVIR, RNA, AXNX, BCAB, BMEA, KZR, KNSA, OLMA, RXDX, RAIN, TPTX, YMTX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 29 2021	RAIN	Rain Therapeutics ...	Cormorant Asset Management, LP		Option Exercise	C	0.00	2,512,561	0	0
Apr 29 2021	RAIN	Rain Therapeutics ...	Cormorant Asset Management, LP		Buy	P	17.00	450,000	7,650,000	2,776,657	2.3 M to 2.8 M (+19.34 %)
Apr 29 2021	RAIN	Rain Therapeutics ...	Cormorant Asset Management, LP		Buy	C	0.00	2,326,657	0	2,326,657	0 to 2.3 M
Apr 19 2021	BMEA	Biomea Fusion, Inc ...	Cormorant Asset Management, LP	Director	Option Exercise	A	17.00	28,911	491,487	28,911
Mar 18 2021	RXDX	Prometheus Bioscie ...	Cormorant Asset Management, LP		Option Exercise	C	0.00	1,084,696	0	0
Mar 18 2021	RXDX	Prometheus Bioscie ...	Cormorant Asset Management, LP		Option Exercise	C	0.00	763,327	0	0
Mar 18 2021	RXDX	Prometheus Bioscie ...	Cormorant Asset Management, LP		Buy	P	19.00	375,000	7,125,000	2,223,022	1.8 M to 2.2 M (+20.29 %)
Mar 18 2021	RXDX	Prometheus Bioscie ...	Cormorant Asset Management, LP		Buy	C	0.00	1,848,022	0	1,848,022	0 to 1.8 M
Dec 22 2020	BCAB	BioAtla, Inc.	Cormorant Asset Management, LP		Option Exercise	C	0.00	1,492,060	0	0
Dec 22 2020	BCAB	BioAtla, Inc.	Cormorant Asset Management, LP		Buy	P	18.00	800,000	14,400,000	2,292,060	1.5 M to 2.3 M (+53.62 %)
Dec 22 2020	BCAB	BioAtla, Inc.	Cormorant Asset Management, LP		Buy	C	0.00	1,492,060	0	1,492,060	0 to 1.5 M
Nov 23 2020	OLMA	Olema Pharmaceutic ...	Cormorant Asset Management, LP		Option Exercise	C	0.00	723,177	0	0
Nov 23 2020	OLMA	Olema Pharmaceutic ...	Cormorant Asset Management, LP		Option Exercise	C	0.00	2,122,367	0	0
Nov 23 2020	OLMA	Olema Pharmaceutic ...	Cormorant Asset Management, LP		Buy	P	19.00	425,000	8,075,000	3,270,544	2.8 M to 3.3 M (+14.94 %)
Nov 23 2020	OLMA	Olema Pharmaceutic ...	Cormorant Asset Management, LP		Buy	C	0.00	2,845,544	0	2,845,544	0 to 2.8 M
Nov 05 2020	AVIR	Atea Pharmaceutica ...	Cormorant Asset Management, LP		Option Exercise	C	0.00	417,360	0	0
Nov 05 2020	AVIR	Atea Pharmaceutica ...	Cormorant Asset Management, LP		Option Exercise	C	0.00	712,250	0	0
Nov 05 2020	AVIR	Atea Pharmaceutica ...	Cormorant Asset Management, LP		Option Exercise	C	0.00	2,631,580	0	0
Nov 05 2020	AVIR	Atea Pharmaceutica ...	Cormorant Asset Management, LP		Option Exercise	C	0.00	1,650,165	0	0
Nov 05 2020	AVIR	Atea Pharmaceutica ...	Cormorant Asset Management, LP		Option Exercise	C	0.00	1,000,000	0	0
Nov 05 2020	AVIR	Atea Pharmaceutica ...	Cormorant Asset Management, LP		Buy	C	0.00	6,411,355	0	6,411,355	0 to 6.4 M
Jun 18 2020	RNA	Avidity Bioscience ...	Cormorant Asset Management, LP		Option Exercise	C	0.00	2,214,545	0	0
Jun 18 2020	RNA	Avidity Bioscience ...	Cormorant Asset Management, LP		Buy	P	18.00	300,000	5,400,000	2,514,545	2.2 M to 2.5 M (+13.55 %)
Jun 18 2020	RNA	Avidity Bioscience ...	Cormorant Asset Management, LP		Buy	C	0.00	2,214,545	0	2,214,545	0 to 2.2 M
May 16 2019	TPTX	Turning Point Ther ...	Cormorant Asset Management, LP	10% Owner	Option Exercise	M	2.19	23,268	51,062	0
May 16 2019	TPTX	Turning Point Ther ...	Cormorant Asset Management, LP	10% Owner	Buy	M	2.19	23,268	51,062	3,122,367	3.1 M to 3.1 M (+0.75 %)
Apr 25 2019	TPTX	Turning Point Ther ...	Cormorant Asset Management, LP	10% Owner	Buy	P	18.00	400,000	7,200,000	3,099,099	2.7 M to 3.1 M (+14.82 %)
Nov 02 2018	AXNX	Axonics Modulation ...	Cormorant Asset Management, LP	10% Owner	Option Exercise	C	0.00	552,495	0	0
Nov 02 2018	AXNX	Axonics Modulation ...	Cormorant Asset Management, LP	10% Owner	Option Exercise	C	0.00	599,999	0	0
Nov 02 2018	AXNX	Axonics Modulation ...	Cormorant Asset Management, LP	10% Owner	Buy	P	15.00	133,333	1,999,995	1,285,827	1.2 M to 1.3 M (+11.57 %)
Nov 02 2018	AXNX	Axonics Modulation ...	Cormorant Asset Management, LP	10% Owner	Buy	C	0.00	552,495	0	1,152,494	600 K to 1.2 M (+92.08 %)
Nov 02 2018	AXNX	Axonics Modulation ...	Cormorant Asset Management, LP	10% Owner	Buy	C	0.00	599,999	0	599,999	0 to 600 K
Jun 27 2018	KZR	Kezar Life Science ...	Cormorant Asset Management, LP	10% Owner	Option Exercise	C	0.00	1,007,421	0	0
Jun 27 2018	KZR	Kezar Life Science ...	Cormorant Asset Management, LP	10% Owner	Option Exercise	C	0.00	315,488	0	0
Jun 27 2018	KZR	Kezar Life Science ...	Cormorant Asset Management, LP	10% Owner	Buy	P	15.00	250,000	3,750,000	1,572,909	1.3 M to 1.6 M (+18.90 %)
Jun 27 2018	KZR	Kezar Life Science ...	Cormorant Asset Management, LP	10% Owner	Buy	C	0.00	1,007,421	0	1,322,909	315.5 K to 1.3 M (+319.32 %)
Jun 27 2018	KZR	Kezar Life Science ...	Cormorant Asset Management, LP	10% Owner	Buy	C	0.00	315,488	0	315,488	0 to 315.5 K
May 31 2018	KNSA	Kiniksa Pharmaceut ...	Cormorant Asset Management, LP	10% Owner	Option Exercise	C	0.00	830,999	0	0
May 31 2018	KNSA	Kiniksa Pharmaceut ...	Cormorant Asset Management, LP	10% Owner	Buy	P	18.00	69,444	1,249,992	900,443	831 K to 900.4 K (+8.36 %)
May 31 2018	KNSA	Kiniksa Pharmaceut ...	Cormorant Asset Management, LP	10% Owner	Buy	C	0.00	830,999	0	830,999	0 to 831 K
Dec 18 2017	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	S	4.88	504,027	2,461,164	3,300,000	2.8 M to 3.3 M (+18.03 %)
Nov 14 2017	APLS	Apellis Pharmaceut ...	Cormorant Asset Management, LL ...	10% Owner	Option Exercise	C	0.00	303,916	0	0
Nov 14 2017	APLS	Apellis Pharmaceut ...	Cormorant Asset Management, LL ...	10% Owner	Option Exercise	C	0.00	2,098,581	0	0
Nov 14 2017	APLS	Apellis Pharmaceut ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	14.00	1,071,428	14,999,992	3,473,925	2.4 M to 3.5 M (+44.60 %)
Nov 14 2017	APLS	Apellis Pharmaceut ...	Cormorant Asset Management, LL ...	10% Owner	Buy	C	0.00	2,402,497	0	2,402,497	0 to 2.4 M
Dec 14 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	10.98	21,301	233,955	3,804,027	3.8 M to 3.8 M (+0.56 %)
Dec 14 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	10.79	100,000	1,078,950	3,782,726	3.7 M to 3.8 M (+2.72 %)
Dec 09 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	10.93	21,819	238,482	3,682,726	3.7 M to 3.7 M (+0.60 %)
Dec 09 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	10.74	22,598	242,707	3,660,907	3.6 M to 3.7 M (+0.62 %)
Dec 06 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	10.89	8,216	89,441	3,638,309	3.6 M to 3.6 M (+0.23 %)
Dec 06 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	10.78	29,757	320,882	3,630,093	3.6 M to 3.6 M (+0.83 %)
Dec 06 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	10.48	50,000	523,800	3,600,336	3.6 M to 3.6 M (+1.41 %)
Dec 01 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	10.11	41,984	424,593	3,550,336	3.5 M to 3.6 M (+1.20 %)
Dec 01 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	10.28	128,407	1,319,523	3,508,352	3.4 M to 3.5 M (+3.80 %)
Nov 23 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	10.67	200	2,134	3,379,945	3.4 M to 3.4 M (+0.01 %)
Nov 23 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	11.37	180,300	2,050,372	3,379,745	3.2 M to 3.4 M (+5.64 %)
Nov 23 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	11.08	69,500	769,817	3,199,445	3.1 M to 3.2 M (+2.22 %)
Nov 23 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	11.64	111,863	1,302,622	3,129,945	3 M to 3.1 M (+3.71 %)
Nov 14 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	11.48	9,500	109,016	3,018,082	3 M to 3 M (+0.32 %)
Nov 14 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	11.46	21,200	242,975	3,008,582	3 M to 3 M (+0.71 %)
Nov 14 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	11.07	216,700	2,398,587	2,987,382	2.8 M to 3 M (+7.82 %)
Nov 14 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	9.68	12,100	117,121	2,770,682	2.8 M to 2.8 M (+0.44 %)
Nov 07 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	8.69	231,700	2,012,616	2,758,582	2.5 M to 2.8 M (+9.17 %)
Nov 07 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	8.09	73,403	594,021	2,526,882	2.5 M to 2.5 M (+2.99 %)
Nov 07 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	7.27	2,597	18,880	2,453,497	2.5 M to 2.5 M (+0.11 %)
Nov 07 2016	PTI	PROTEOSTASIS THERA ...	Cormorant Asset Management, LL ...	10% Owner	Buy	P	7.24	20,277	146,763	2,450,882	2.4 M to 2.5 M (+0.83 %)

Page: 1